Retracted: Role of CD 20 in Physiopathology of Hodgkin’s Disease
DOI:
https://doi.org/10.3329/jom.v19i2.37232Keywords:
Hodgkin Disease, CD20 Antigen, Physiopathology, RituximabAbstract
The following retraction notice appears in this issue Vol.19(2) 2018 http://dx.doi.org/10.3329/jom.v19i2.37864
On 10th August 2018 the Editorial Board of Journal of Medicine agreed to retract the article ‘Role of CD 20 in Physiopathology of Hodgkin’s Disease’ published in Journal of Medicine, Vol.19(2) pages 119-122 (DOI: https://www.banglajol.info/index.php/JOM/article/view/37232) as it was found to be a duplicate publication of the following published article: ‘CD20 role in pathophysiology of Hodgkin’s disease’ by Marcelo Antônio Oliveira Santos and Marinus de Moraes Lima published in Revista da Associação Médica Brasileira, Vol.63(9) pages 810-813 http://dx.doi.org/10.1590/1806-9282.63.09.810.
J MEDICINE JUL 2018; 19 (2) : 119-122
Downloads
7
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).